Alzheimer's disease is a progressive neurodegenerative disorder that gradually destroys memory, thinking abilities, and eventually the capacity to perform even the simplest tasks. Named after German psychiatrist Alois Alzheimer, who firs…
In Alzheimer's disease, a protein called amyloid precursor protein (APP) gets snipped by enzymes in the wrong places, producing sticky fragments called beta-amyloid peptides. These fragments cluster together like oil droplets in water, forming progressively larger clumps that eventually become dense plaques scattered throughout the brain's outer layers. The plaques settle in the spaces between neurons, particularly in memory-forming regions like the hippocampus and cerebral cortex.
These amyloid deposits act like biological debris piles that interfere with the precise chemical signaling neurons need to communicate. The plaques also trigger inflammatory responses and may directly damage the delicate neuronal membranes they contact. While some amyloid naturally accumulates with normal aging, Alzheimer's patients develop far more plaques, and they appear decades before symptoms emerge, suggesting they initiate a destructive cascade that ultimately kills brain cells.
Tau is normally a helpful protein that stabilizes microtubules—the internal scaffolding that gives neurons their shape and serves as railways for transporting nutrients and signals. In Alzheimer's disease, tau proteins become chemically altered through excessive phosphorylation, which attaches too many phosphate chemical groups to the protein. This modification causes tau to detach from the microtubules and stick to other tau molecules instead.
The rogue tau proteins twist together into paired helical filaments, forming dense tangles inside the neuron's body and branches. These neurofibrillary tangles essentially clog the cell's internal transport system, like twisted wreckage blocking a highway. Without functioning microtubules, neurons cannot move essential supplies where needed, cannot maintain their long projections, and cannot clear out cellular waste.
The tangles spread through the brain in a predictable pattern, moving from the memory centers to other regions as the disease progresses. Unlike amyloid plaques that sit between cells, tau tangles directly correlate with symptom severity—the more tangles present, the worse the cognitive impairment, because these tangles represent neurons in the process of dying or already dead.
Synapses are the specialized junctions where neurons pass signals to one another using chemical messengers called neurotransmitters. A single neuron may have thousands of these connection points, forming the intricate networks underlying every thought, memory, and action. In Alzheimer's disease, synapses begin failing and disappearing long before the neurons themselves die, particularly in brain circuits responsible for forming and retrieving memories.
The synaptic damage results from multiple assaults: soluble amyloid fragments directly impair the molecular machinery that receives signals, tau tangles prevent the transport of essential components to maintain synapses, and the overall toxic environment disrupts the careful balance of neurotransmitters. Acetylcholine—a neurotransmitter critical for attention and memory—becomes especially depleted as the neurons producing it degenerate.
This synaptic loss represents the primary biological correlate of cognitive decline in Alzheimer's patients. When synapses disconnect, the brain's information processing capacity diminishes dramatically, like a computer losing connections between its circuits. Even surviving neurons become isolated, unable to participate in the networks that encode experiences or retrieve stored knowledge, which explains why learned skills and cherished memories become inaccessible.
Microglia are the brain's resident immune cells, normally acting as vigilant custodians that clear debris, fight infections, and support neuron health. In Alzheimer's disease, microglia become chronically activated when they encounter amyloid plaques and degenerating neurons. Initially, they attempt to engulf and remove the plaques, but the sheer volume of pathology overwhelms them, triggering a sustained inflammatory response.
The activated microglia release inflammatory molecules called cytokines and chemokines, chemical signals intended to recruit help and destroy threats. However, in Alzheimer's, this inflammation becomes chronic rather than resolving, creating a toxic environment that damages healthy neurons caught in the crossfire. The inflamed microglia also produce reactive oxygen species—chemically aggressive molecules that damage cell membranes, proteins, and DNA.
Genetic studies have revealed that many risk factors for Alzheimer's involve genes that control microglial function, suggesting immune dysfunction plays a causal role rather than being merely a reaction to damage. This chronic neuroinflammation creates a vicious cycle: damaged neurons release distress signals that activate more microglia, which then produce inflammatory molecules that damage additional neurons, perpetuating the brain's decline.
As Alzheimer's progresses, the accumulated damage from plaques, tangles, synaptic loss, and inflammation leads to wholesale neuron death. When neurons die, they take their irreplaceable functions with them—the brain cannot regenerate these cells the way skin or liver can replace damaged tissue. This neuronal death occurs on a massive scale, with billions of cells lost over the disease's course, causing affected brain regions to physically shrink.
The atrophy follows a characteristic geographic pattern visible on brain scans. The hippocampus—the seahorse-shaped structure essential for forming new memories—typically shrinks earliest and most dramatically, explaining why recent memory loss is the hallmark early symptom. As disease spreads, the cerebral cortex thins significantly, with the temporal and parietal lobes showing pronounced volume loss, correlating with declining language abilities and spatial reasoning.
This brain tissue loss is substantial and measurable: advanced Alzheimer's patients may lose 20 percent or more of their total brain volume compared to healthy individuals. The ventricles—fluid-filled spaces inside the brain—expand to fill the void left by vanished tissue. In the end stages, a brain ravaged by Alzheimer's can weigh 30 percent less than a healthy brain, representing the physical destruction of the biological substrate that once held a lifetime of memories, personality, and cognitive abilities.